LVR-Klinikum Düsseldorf Hospital of the Heinrich-Heine University ...

LVR-KLINIKUM DÜsseLDORF – hOsPITaL OF The heINRIch-heINe UNIVeRsITY DÜsseLDORF
controlled trial within the German Research Network on Schizophrenia.
J Clin Psychiatry 68: 1763–1774
Gaebel W, Roeder N, Janssen B, Kastenholz H (2007): Qualitätssicherung.
Der Weg ist das Ziel. Dt Ärzteblatt 104: 844–846
Gaebel W, Wölwer W (2007) (Hrsg.): 1st European Conference on Schizophrenia
Research. Perspectives from European networks. 26–28
September 2007, Düsseldorf, Germany. Europ Arch Psych Clin
Neurosc 257: 1–40
Gaebel W, Zielasek J, Müller U (2007): Psychiatry in Germany. International
Psychiatry 4: 61–63
Gaebel W, Zielasek J (2007): Demenz: Herausforderung für Individuum
und Gesellschaft. Vita nostra Rev 16 (S1): 80–85
Gallinat J, Götz T, Kalus P, Bajbouj M, Sander T, Winterer G (2007):
Genetic variations of the NR3A subunit of the NMDA receptor modulate
prefrontal cerebral activity in humans. J Cogn Neurosci19:
59–68
Höhl W (2007): Tests unter der Lupe: Das Osnabrücker Arbeitsfähigkeitenprofil
(O-AFP). Ergotherapie & Rehabilitation 6: 10–13
Jäger M, Riedel M, Messer Th, Laux G, Pfeiffer H, Naber D, Schmitz
LG, Gaebel W, Huff W, Heuser I, Kühn KU, Lemke MR, Rüther
E, Buchkremer G, Gastpar M, Bottlender R, Strauß A, Müller HJ
(2007): Psychopathological characteristics and treatment response
of first episode compared with multiple episode schizophrenic disorders).
Eur Arch Psychiatry Clin Neurosci 257: 47–53
John ER, Prichep LS, Winterer G, Herrmann WM, di Michele F, Halper
J, Bolwig TG, Cancro R (2007): Electrophysiological subtypes
of psychotic states. Acta Psychiatr Scand 116: 17–35. Erratum in:
Acta Psychiatr Scand 116: 35
Kessler H, Supprian T, Falkai P (2007): Pharmakologische Behandlungsansätze
bei frontotemporaler Demenz. Fortschr Neurol Psychiatr
75: 714–719
Kirschbaum KM, Müller MJ, Malevani J, Mobascher A, Burchardt C,
Piel M, Hiemke C (2007): Serum levels of aripiprazole and dehydroaripiprazole,
clinical response and side effects. World J Biol Psychiatry
9: 212–218
Koethe D, Jülicher A, Nolden BM, Klosterkötter J, Niklewski G,
Wodarz N, Klatt J, Burtscheidt W, Gaebel W, Leweke FM (2007):
Oxcarbazepine – efficacy and tolerability during treatment of
alcohol withdrawal. Alcohol Clin Exp Res 31: 1–7
Kornischka J, Cordes J, Agelink MW (2007): 40 Years Beta-Adrenoceptor
Blockers in Psychiatry. Fortschr Neurol Psychiatr 75:
199–210
Lang UE, Sander T, Lohoff FW, Hellweg R, Bajbouj M, Winterer G,
Gallinat J (2007): Association of the met66 allele of brain-derived
neurotrophic factor (BDNF) with Smoking. Psychopharmacology
190: 433–439
130
Lange-Asschenfeldt C (2007): Ergänzungen zur Krankheit Robert
Schumanns aus neurologischer Sicht. Dt Ärzteblatt 103: 2699–
2700
Lange-Asschenfeldt C, Lohmann P, Riepe MW (2007): Hippocampal
synaptic depression following spatial learning in a complex maze.
Exp Neurology 203: 481–485
Lange-Asschenfeldt C, Lohmann P, Riepe MW (2007): Spatial performance
in a complex maze is associated with persistent long-term
potentiation enhancement in mouse hippocampal slices at early
training stages. Neuroscience 147: 318–32
Lange-Asschenfeldt C, Schipke CG, Riepe MW (2007): Multimodal
gain control at the hippocampal Schaffer collateral-CA1 synapse.
Neurosci Lett 416: 101–105
Lange-Asschenfeldt C, Blaeser I, Supprian T (2007): Bipolar
switching after carbamazepine withdrawal. Pharmacopsychiatry
40: 86–87
List M, Hoffmann F, Supprian T (2007): Rechtliche Aspekte freiheitsbeschränkender
Maßnahmen in der Versorgung Demenzkranker
in Pflegeheimen. NeuroGeriatrie 4: 73–78
Mobascher A, Mobascher J, Schmahl C, Malevani J (2007): Behandlung
der Borderline-Persönlichkeitsstörung mit atypischen Antipsychotika.
Nervenarzt 78: 1003–1013
Musso F, Bettermann F, Vucurevic G, Stoeter P, Konrad A, Winterer
G (2007): Smoking impacts on prefrontal attentional network function
in young adult brains. Psychopharmacology 191: 159–169
Reske M, Kellermann T, Habel U, Shah J, Backes V, von Wilmsdorf
M, Stöcker T, Gaebel W, Schneider F (2007): Stability of emotional
dysfunctions? A long-term fMRI study in first-episode schizophrenia.
Psychiatry Res 155: 103–112
Ruhrmann S, Bechdolf A, Kühn KU, Wagner M, Schultze-Lutter F,
Janssen B, Maurer K, Häfner H, Gaebel W, Möller HJ, Maier W,
Klosterkötter J (2007): Acute effects of treatment for prodromal
symptoms people putatively in a late initial prodromal state of psychosis.
Br J Psychiatry 191 (Suppl): 88–95
Schneider F, Habel U, Klein M, Kellermann T, Stöcker T, Shah J, Zilles
K, Braus DF, Schmitt A, Schlösser R, Wagner M, Frommann I,
Kircher T, Rapp A, Meisenzahl E, Ufer S, Ruhrmann S, Thienel R,
Sauer H, Henn F, Gaebel W (2007): Neural correlates of working
memory dysfunction in first-episode schizophrenia patients: An
fMRI multicenter study. Schizophrenia Res 89: 198–210
Stamm K, Salize HJ, Härter M, Brand S, Sitta P, Berger M, Gaebel
W, Schneider F (2007): Ressourcenverbrauch stationärer Episoden
bei depressiven Störungen. Nervenarzt 6: 665–671
Westheide J, Cohen S, Bender S, Cooper-Mahkorn D, Erfurth A,
Gastpar M, Huber TJ, Maier W, Murafi W, Rothermund M, Signerski
J, Sträter B, Teusch L, Weig W, Welling A, Kühn KU (2007): Sexual
dysfunction in psychiatric inpatients: The role of antipsychotic
medication. Pharmacopsychiatry 40: 140–145